These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 1367251)
1. Optimization of cell culture conditions for production of biologically active proteins. Hosoi S; Miyaji H; Satoh M; Kurimoto T; Mihara A; Fujiyoshi N; Itoh S; Sato S Cytotechnology; 1991; 5 Suppl 2():S17-34. PubMed ID: 1367251 [TBL] [Abstract][Full Text] [Related]
2. [Production of useful recombinant proteins using Namalwa KJM-1 cells adapted to serum-free medium]. Hosoi S Hum Cell; 1991 Dec; 4(4):321-8. PubMed ID: 1817647 [TBL] [Abstract][Full Text] [Related]
3. Optimization of cell culture conditions for production of biologically active proteins. Hosoi S; Miyaji H; Satoh M; Kurimoto T; Mihara A; Fujiyoshi N; Itoh S; Sato S Cytotechnology; 1991 Jan; 5(Suppl 2):17-34. PubMed ID: 22359044 [TBL] [Abstract][Full Text] [Related]
4. Serum-free cultivation of anchorage-dependent cells on microcarrier: effective production of human macrophage colony-stimulating factor. Satoh S; Kobayashi J; Mizoguchi J; Nogawa M; Otani M Cytotechnology; 1991; 5 Suppl 2():S95-114. PubMed ID: 1367256 [TBL] [Abstract][Full Text] [Related]
5. Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium. Miyaji H; Harada N; Mizukami T; Sato S; Fujiyoshi N; Itoh S Cytotechnology; 1990 Jul; 4(1):39-43. PubMed ID: 1369278 [TBL] [Abstract][Full Text] [Related]
6. Optimization of cell culture conditions for G-CSF (granulocyte-colony stimulating factor) production by genetically engineered Namalwa KJM-1 cells. Hosoi S; Murosumi K; Sasaki K; Satoh M; Miyaji H; Hasegawa M; Itoh S; Tamaoki T; Sato S Cytotechnology; 1991 Sep; 7(1):25-32. PubMed ID: 1370059 [TBL] [Abstract][Full Text] [Related]
7. Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapted to serum-free medium by a dhfr gene coamplification method. Miyaji H; Harada N; Mizukami T; Sato S; Fujiyoshi N; Itoh S Cytotechnology; 1990 Sep; 4(2):173-80. PubMed ID: 1367043 [TBL] [Abstract][Full Text] [Related]
8. Stable production of recombinant pro-urokinase by human lymphoblastoid Namalwa KJM-1 cells: host-cell dependency of the expressed-protein stability. Satoh M; Hosoi S; Miyaji H; Itoh S; Sato S Cytotechnology; 1993; 13(2):79-88. PubMed ID: 7764581 [TBL] [Abstract][Full Text] [Related]
9. Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium. Miyaji H; Mizukami T; Hosoi S; Sato S; Fujiyoshi N; Itoh S Cytotechnology; 1990 Mar; 3(2):133-40. PubMed ID: 1366592 [TBL] [Abstract][Full Text] [Related]
10. High-level expression and purification of a recombinant human alpha-1, 3-fucosyltransferase in baculovirus-infected insect cells. Shinkai A; Shinoda K; Sasaki K; Morishita Y; Nishi T; Matsuda Y; Takahashi I; Anazawa H Protein Expr Purif; 1997 Aug; 10(3):379-85. PubMed ID: 9268686 [TBL] [Abstract][Full Text] [Related]
11. Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture. Haldankar R; Kopchick JJ; Ridgway D Biotechnol Prog; 1999; 15(3):336-46. PubMed ID: 10356250 [TBL] [Abstract][Full Text] [Related]
12. Appropriate mammalian expression systems for biopharmaceuticals. Werner RG; Noé W; Kopp K; Schlüter M Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718 [TBL] [Abstract][Full Text] [Related]
13. Continuous large-scale production of the cytokine CXCL8 from a novel porcine cell line. Shirai J; Ogihara K; Masumoto A; Morioka K; Naya Y; Tsuchiya Y; Yokomizo Y Eur Cytokine Netw; 2007 Mar; 18(1):14-22. PubMed ID: 17400534 [TBL] [Abstract][Full Text] [Related]
14. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium. Yamaguchi N; Yamamura Y; Koyama K; Ohtsuji E; Imanishi J; Ashihara T Cancer Res; 1990 Nov; 50(21):7008-14. PubMed ID: 2208167 [TBL] [Abstract][Full Text] [Related]
15. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907 [TBL] [Abstract][Full Text] [Related]
16. Suspension culture process of MethA tumor cell for the production of heat-shock protein glycoprotein 96: process optimization in spinner flasks. Tang YJ; Li HM; Hamel JF Biotechnol Prog; 2007; 23(6):1363-77. PubMed ID: 17944484 [TBL] [Abstract][Full Text] [Related]
17. Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system. Magistrelli G; Malinge P; Lissilaa R; Fagète S; Guilhot F; Moine V; Buatois V; Delneste Y; Kellenberger S; Gueneau F; Ravn U; Kosco-Vilbois M; Fischer N Protein Expr Purif; 2010 Aug; 72(2):209-16. PubMed ID: 20399863 [TBL] [Abstract][Full Text] [Related]
18. Selective assembly of laminin variants by human carcinoma cells. Wewer UM; Wayner EA; Hoffstrom BG; Lan F; Meyer-Nielsen B; Engvall E; Albrechtsen R Lab Invest; 1994 Nov; 71(5):719-30. PubMed ID: 7967523 [TBL] [Abstract][Full Text] [Related]
19. High-level expression of secreted proteins from cells adapted to serum-free suspension culture. Berg DT; McClure DB; Grinnell BW Biotechniques; 1993 Jun; 14(6):972-8. PubMed ID: 8333965 [TBL] [Abstract][Full Text] [Related]
20. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Gruss HJ; Brach MA; Drexler HG; Bonifer R; Mertelsmann RH; Herrmann F Cancer Res; 1992 Jun; 52(12):3353-60. PubMed ID: 1596893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]